497 A Study of ALPN-202, a PD-L1-dependent CD28 costimulator and dual checkpoint inhibitor, in combination with pembrolizumab in patients with advanced malignancies
oleh: Kristi Manjarrez, Amita Patnaik, Meredith McKean, Michael Chisamore, Nehal Lakhani, Hany Zayed, Zelanna Goldberg, Stanford Peng
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.